Connect with us

Technology

Spatz Medical Marks Milestone: Spatz3 Adjustable Gastric Balloon Launches in the U.S. in March 2024

Published

on

FORT LAUDERDALE, Fla., Feb. 29, 2024 /PRNewswire/ — Spatz Medical, a global leader in gastrointestinal weight loss solutions, is delighted to announce the commencement of commercialization of the Spatz3 Adjustable Gastric Balloon. With over 150,000 patients benefiting from the Spatz3 across more than sixty markets globally, the company is now poised to launch this revolutionary technology in the United States.

 

Spatz3 – Transforming Weight Loss with Adjustability

The Spatz3 Adjustable Gastric Balloon, renowned as the first and only adjustable gastric balloon, has earned widespread acclaim for its outstanding weight loss results and an impressive 84% success rate, as demonstrated in the FDA Pivotal trials and real-world applications. Developed by Dr. Jeffrey Brooks, CEO of Spatz Medical, the Spatz3 introduces a unique adjustability feature, allowing physicians to customize the balloon volume during the treatment period, addressing key challenges faced by traditional gastric balloon systems.

Clinical Trial Results from Pivotal Study:

The Spatz3’s efficacy and safety profile, as reported in the FDA Pivotal Study and published in The Lancet, established a new threshold for Intragastric Balloon results. Noteworthy outcomes include:

Fivefold Greater Weight Loss: Spatz3 Balloon patients achieved a remarkable 15% reduction in initial weight, in contrast to the control group’s 3% weight loss.Successful Weight Maintenance: 74.3% of patients maintained clinically significant weight loss for six months after balloon removal.Customized Adjustments: The adjustability feature played a crucial role, with down adjustments alleviating intolerance in 82% of cases and up adjustments at 18 weeks resulting in an additional 15.2% excess weight loss.Extended Treatment Time: the Spatz3 is approved for an 8-month treatment period, leading to more successful patient outcomes when compared to a standard, non-adjustable 6-month balloon.

Dr. Jeffrey Brooks on the Milestone Achievement

Dr. Jeffrey Brooks expressed his enthusiasm for this milestone, stating, “The completion of the FDA Post Approval Study enrollment and the affirmation of our clinical trial results mark a pivotal moment for Spatz Medical. For the first time in gastric balloon history, an adjustable gastric balloon affords patients a decision making role in their weight loss therapy, customized to their needs. That is reflected in the outstanding 15% weight loss and 84% success rate, not previously achieved by gastric balloons in FDA trials. With a substantial global presence and over 150,000 patients benefiting from Spatz3, we are thrilled to bring this proven solution to individuals across the United States.”

Comments from Professor Barham Abu Dayyeh MD, Internationally Renowned Innovator and Investigator of Bariatric Endoscopic procedures in the US.

Professor Abu Dayyeh, Principal Investigator of the Spatz3 FDA Pivotal Trial and Post Approval Study stated,

“The Spatz3 brings a new dimension in endoscopic bariatrics with its proprietary adjustability technology. The ability to change balloon volume during the course of treatment yielded an impressive 15% total body weight loss and 84% response rate in FDA clinical trials. Spatz will be an important and welcome addition to the endoscopic bariatric options in the US.”

Continued Commitment to Innovation

Spatz Medical remains committed to advancing the field of bariatric endoscopy through continued innovation. The Spatz3’s adjustability feature is a paradigm shift for intragastric balloons. It offers new possibilities for patients, including alleviating symptoms of balloon intolerance, preventing early intolerance with gradual filling of the balloon, and a rejuvenation option for those experiencing weight loss plateaus.

The Spatz3 is approved for use in adults with obesity and provides a customizable approach to weight loss for individuals who have not achieved desired results through supervised weight control programs, or who have failed with standard non-adjustable balloons.

For more information about Spatz Medical and the Spatz3 Adjustable Gastric Balloon, please visit www.SpatzMedical.com.

Media contact:
Mickey Nave
mickey@spatzmedical.com

Logo – https://mma.prnewswire.com/media/1730863/3302275/Spatz_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/spatz-medical-marks-milestone-spatz3-adjustable-gastric-balloon-launches-in-the-us-in-march-2024-302075949.html

SOURCE Spatz Medical

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Shoplazza Launches the World’s First AI-Native Commerce Operating System with a Unified Suite of AI Agents

Published

on

By

TORONTO, April 20, 2026 /PRNewswire/ — Shoplazza, a leading global commerce platform, announced the launch of the world’s first AI native commerce operating system recently, along with a unified suite of AI agents designed to execute across the entire ecommerce lifecycle. The release marks a major step forward in the company’s evolution from a traditional software platform to an AI-driven commerce infrastructure built for global scale.

At the core of the system is Shoplazza AI Store Builder, an intelligent agent that fundamentally changes how online stores are created. Instead of configuring tools manually, merchants can now generate fully functional, ready to sell storefronts through simple natural language input. By interpreting product information, target markets, and customer profiles, the system automatically builds site architecture, generates localized content, and provides initial go to market recommendations. What once required weeks of setup can now be completed in minutes, with a complete store and launch ready foundation.

Shoplazza also introduced LazzaStudio, an AI powered visual creation agent that streamlines how merchants produce content at scale. From product imagery to marketing creatives and campaign visuals, LazzaStudio transforms traditionally complex production workflows into a prompt driven process. With built in brand learning capabilities, the system generates consistent, high quality assets tailored for global audiences, enabling merchants to deploy content seamlessly across storefronts and advertising channels while significantly reducing production time and cost.

To complete the growth loop, Shoplazza launched AdValet, an AI advertising agent that automates campaign execution end to end. AdValet translates product data and market signals into audience targeting, creative generation, media planning, and campaign deployment. During live campaigns, it continuously monitors performance and dynamically optimizes outcomes through real time feedback and model iteration. This shifts advertising from manual, experience based trial and error to a system of continuous, AI-driven performance optimization.

These agents operate together within Shoplazza’s AI-native commerce operating system, where merchant intent is translated directly into coordinated execution. By unifying store creation, content production, and marketing into a single system, Shoplazza replaces fragmented workflows with an integrated layer of automation that enables faster, more predictable growth.

Shoplazza currently supports more than 650,000 merchants worldwide. With its AI-native architecture, the platform brings together previously disconnected capabilities into a single intelligent system, delivering improvements in efficiency, scalability, and operational reliability for businesses operating in increasingly complex global markets.

Looking ahead, Shoplazza will introduce Athena very soon, an AI admin agent designed to extend automation into day to day business management. Covering areas such as product management, order processing, analytics, and content operations, Athena allows merchants to interact with the system conversationally while orchestrating multiple agents in the background. This will complete a fully connected agent ecosystem spanning store creation, creative production, marketing execution, and ongoing operations.

“Commerce has reached a point where adding more tools no longer solves the problem,” said Jeff Li, Founder and CEO of Shoplazza. “What merchants need is a system that can understand intent and execute across the entire business. That is what we are building with our AI native commerce operating system. It is not just about making things easier. It is about making outcomes more predictable, scalable, and aligned with how modern commerce actually operates.”

About Shoplazza

Shoplazza is a global AI-native commerce operating system that enables brands to build, launch, and scale their online businesses. Built on an AI agent-native framework, Shoplazza integrates storefronts, marketing, payments, and operational workflows into a unified system designed to support scalable, long-term growth across global markets. Learn more at https://www.shoplazza.com/.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoplazza-launches-the-worlds-first-ai-native-commerce-operating-system-with-a-unified-suite-of-ai-agents-302746904.html

SOURCE Shoplazza

Continue Reading

Technology

Pricer and JRTech Solutions sign 51 MUSD digital store transformation deal with Sobeys in Canada

Published

on

By

MONTREAL, April 20, 2026 /PRNewswire/ – Pricer AB, a global leader in digital shelf-edge solutions, announces that its Canadian partner JRTech Solutions has signed a major agreement with Sobeys, one of Canada’s leading supermarket chains. The contract includes the deployment of Pricer’s latest electronic shelf label (ESL) technology and the cloud-based platform Pricer Plaza across an estimated 300–350 stores.

The agreement covers the supply of multicolor electronic shelf labels and the necessary store infrastructure, with a total hardware and infrastructure value of approximately 51 MUSD (excluding Pricer Plaza). The deployment is scheduled for an 18-month period starting in May 2026.

“We are very grateful for the trust and that Sobeys has once again chosen Pricer as its long-term strategic partner,” says Mats Arnehall, Chief Growth Officer at Pricer. “This deal confirms our leading position in the North American market and the value of our high-performance system in high-density retail environments. Our scalable cloud platform, Pricer Plaza, will be the intelligence behind every label, enabling Sobeys to act faster and work smarter.”

“After years of close collaboration and shared success, we’re proud to grow our partnership with Sobeys even further with an expanded rollout,” says Diego Mazzone, President and CEO of JRTech Solutions. “That momentum is driven by our ability to consistently deliver reliable, high-quality solutions in complex retail environments. Together, we are positioning our digital smart labels at the heart of a broader digital transformation, driving operational excellence, unlocking real-time intelligence, and creating meaningful value for both Sobeys and their customers.”

Orders will be included in Pricer’s order intake as they are received.

About JRTech Solutions
JRTech Solutions Inc. is the leading North American turnkey Electronic Shelf Label (ESL) provider and the largest worldwide distributor of Pricer ESLs, involved in over 2,000 store installations since 2008. JRTech Solutions is the exclusive Canadian provider of AI-powered inventory scanning robotics powered by Brain Corp for automated inventory management.
For further information: www.jrtechsolutions.com

About Pricer
Pricer is a pioneer and partner for in-store communication and digitalization in the rapidly evolving retail tech landscape. As a global technology leader, we empower leading retailers worldwide to shape effortless and inspiring shopping experiences that fundamentally change buying behaviors, boost sales, and drive operational efficiency. Leveraging cutting-edge innovation, we deliver scalable, high-performing solutions that easily integrate with existing systems, are energy-efficient, and user-friendly. Founded in Sweden in 1991 and listed on Nasdaq Stockholm, Pricer has delivered over 380 million electronic shelf labels in more than 28,000 stores across more than 80 countries.
For further information, please visit www.pricer.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/pricer-and-jrtech-solutions-sign-51-musd-digital-store-transformation-deal-with-sobeys-in-canada-302746808.html

SOURCE JRTECH SOLUTIONS INC.

Continue Reading

Technology

Mitate Zepto Technica Joins JST’s Next-generation Edge AI Semiconductor R&D Program as Social Implementation Partner

Published

on

By

– MZT to Lead Product Commercialization through Its Genome-analysis Accelerator “RASEN” –

TOKYO, April 20, 2026 /PRNewswire/ — Mitate Zepto Technica, Inc. (hereinafter “MZT”), based in Tokyo’s Shibuya district, announced on April 20 that it has joined the national research initiative “Next-Generation Edge AI Semiconductor Research and Development Program” promoted by the Japan Science and Technology Agency (JST). MZT participates as a designated social implementation and commercialization partner for the research theme “Accelerating Edge Intelligence for AI for Science” (Principal Investigator: Makoto Taiji, Program Director, TRIP Headquarters, RIKEN).

Logo: https://kyodonewsprwire.jp/img/202604167540-O1-5Sz6I68Q 

This research theme aims to achieve advanced computational infrastructure through the integration of AI technology and next-generation edge semiconductors, with genome analysis as one of its key application domains. MZT participates as an organization responsible for the productization and social implementation of research outcomes through its proprietary genome-analysis accelerator “RASEN.”

Background

Since its founding in 2020, MZT has pursued a distinctive approach to genome analysis: purpose-built ASIC acceleration. Following technology validation through joint research with Tohoku University and other partners, MZT now participates as an R&D institution responsible for social implementation under this research theme.

MZT’s Role in the Program

Within this research theme, MZT will integrate AI research outcomes from RIKEN and Tohoku University into the RASEN architecture, and lead the R&D work toward social implementation through ASIC development and productization. As the industrial partner bridging research and real-world deployment, the company targets social implementation by 2029.

Program Overview

Research theme: Accelerating edge intelligence for AI for science
Promoting agency: Japan Science and Technology Agency (JST)
Principal investigator: Makoto Taiji, Program Director, TRIP Headquarters, RIKEN
Participating institutions: RIKEN, Tohoku University, Keio University, Mitate Zepto Technica
MZT’s participation start: April 2026 (FY2026)
JST program period: FY2025 onwards

Comment from Keisuke Harashima, President & CEO, Mitate Zepto Technica:
“It is a tremendous honor that we can lead the social implementation of this research theme through the acceleration of genome analysis via dedicated semiconductors — a challenge we have pursued since MZT’s founding. RASEN is at exactly the right inflection point, transitioning from research to real-world deployment. We will use this participation to accelerate commercialization across healthcare, drug discovery, and research infrastructure.”

About RASEN

RASEN is MZT’s proprietary genome-analysis accelerator under development, built on a purpose-designed ASIC architecture. In internal validation, RASEN has demonstrated the ability to complete whole-genome sequencing (WGS) analysis in approximately 5 minutes on a standard workstation — without the need for supercomputers or high-performance computing infrastructure. In independent validation studies conducted with Tohoku University, RASEN achieved 99.8% concordance with conventional analysis methods across 12 samples, confirming that its speed advantage does not come at the cost of accuracy.

About Mitate Zepto Technica

Mitate Zepto Technica is a Japanese deep-tech startup developing purpose-built semiconductor solutions for genome analysis. By harnessing cutting-edge chip technology, MZT aims to deliver transformative speed improvements in genomic computation –contributing to the resolution of global challenges in healthcare, food security, and energy through its proprietary products.

Website: https://mitatezeptotechnica.com/en/company/ 

View original content:https://www.prnewswire.com/news-releases/mitate-zepto-technica-joins-jsts-next-generation-edge-ai-semiconductor-rd-program-as-social-implementation-partner-302746768.html

SOURCE Mitate Zepto Technica, Inc.

Continue Reading

Trending